AI Medical Technology is a company operating in the interdisciplinary fields of data science, software development, and medicine. Founded by a diverse team of driven, passionate tech entrepreneurs, software developers and clinicians, we are dedicated to developing AI powered diagnostic solutions that enable frontline healthcare practitioners to make easier, faster, more cost effective and more reliable diagnoses for their patients.
Having raised initial funding in 2021 we are now focussed on bringing our first solution, Dermalyser, through clinical trials and into market.
Meet our team
We are a cross disciplinary team of computer scientists, clinicians and entrepreneurs united by our passion to develop solutions that harness the power of AI which enable healthcare providers to provide easier, faster and more cost effective diagnosis.
Christoffer Ekström is one of the founders of AI Medical Technology and is the company’s CEO and one of the board members. He is a serial entrepreneur and holds a Master’s degree in immersive technologies (M.Sc.) from Stockholm University and finalising a bachelor’s degree in business administration (BBA) at Uppsala University. Christoffer is an experienced climber and adventurer.
Haleh has a PhD in Medicine and works today as a Senior Medical Advisor in the Life Science industry. Haleh builds and maintains relationships with KOLs, stakeholders and investors. She is also responsible for all the company’s medical and scientific data communication and medical activities.
Fredrik has a PhD in computer science from the Royal Institute of Technology (KTH) and a background as Associate Professor (docent) at Umeå University. He has long experience as an entrepreneur and CTO of both startups and from larger and, more mature companies. Besides a great interest in technology, Fredrik is also an avid skier and motorcyclist.
Niya Thomas is our Quality and Regulatory Affairs manager. She holds her global masters degree in Bio-entrepreneurship from Karolinska Institutet and a dual BS-MS degree in biological sciences from Indian Institute of Science Education and Research Thiruvananthapuram. A young culinary aficionado at heart, Niya enjoys her weekends going on culinary jaunts with her friends, exploring Stockholm’s diverse food scene.
Jonatan Helenason is one of the founders of AI Medical Technology, and besides working as a lead developer, he is the company’s Supply Manager. He holds a Master’s degree in immersive technologies (M.Sc.) from Stockholm University. While Jonatan enjoys travelling, he is, in the most positive sense, a nerd at heart and loves everything about programming, popular science and new technology.
Jens Dolve is one of the founders of AI Medical Technology and is the company’s CFO. Previous experience includes Ernst & Young, Capgemini within Assurance, Transaction Advisory and Finance Transformation. Jens holds a M.Sc. in Economics and Business Administration from Lund’s University and studies in Financial Management at Sydney University.
Panos Papachristou is a co-founder of AI Medical Technology. He is a specialist physician in Family Medicine with a broad background from the fields of Biomedicine and Medicine. He holds a PhD from Karolinska Institutet where he is affiliated to continued research. Panos is a passionate serial house renovator.
Magnus Falk is a general practitioner and associate professor in general practice at Linköping University. He has broad and long-time experience as a clinical researcher in the field of skin cancer diagnosis and prevention, with specific emphasis on primary care, including methods to improve early skin cancer detection. Besides his scientific publications, he also enjoys writing novels in his leisure time.
Meet our board
Pär Nordström holds a Master’s degree in engineering physics from KTH. With more than three decades in the global medical device industry, then serving as an Investment manager at Almi Invest, he has gained extensive experience in Medical devices, board work and startups. He currently serves on the board of three medical technology startups. Apart from his engagement in Medtech startups, he enjoys spending time in his house and on the golf courses in Southern Sweden.
Agneta Franksson holds an MBA from Uppsala University and a Master’s degree from KTH, Stockholm. She has more than 25 years of experience in R&D, including clinical trials, product development, sales, marketing and CEO roles. Recently she has served as Sales Director at Tieto Healthcare & Welfare. Agneta has worked on about twenty boards since 2012. Her board experience spans both owner-managed and public companies, and she has received the national award “Supergasell 2016”, Dagens Industri.
Over 30 years of experience within the Life Science industry, with several recent senior positions in private equity environment. Emil was recently Senior Advisor to the merged BSN Medical/SCA unit. Before the merger, he was Chief Commercial Officer. Emil is CEO of Bonesupport, a medical technology company listed on NASDAQ Stockholm.
More than 30 years of experience in ensuring predictable and sustainable market access globally in Life Science. Spent 15 years in senior global leadership roles within Elekta and GE Healthcare. Peter serves as a senior advisor to more than 15 medical device companies.
Meet our advisory board
A board member for the European Academy of Dermatology and Venereology. Olle is also part of the Swedish Medicines Agency's scientific council, and is part of the Medical Law Council, consisting of professionals, private and public care management representatives.
Professor Kittler is an internationally well-known dual medical specialist in Dermatology and skin pathology. He is a senior researcher interested in dermoscopy and dermatopathology at Vienna University. Prof Kittler is the author of several books on dermoscopy and melanoma.
The chief physician at Uppsala Academic Hospital’s oncology clinic. Gustav is the group manager for malignant melanoma at Uppsala Academic Hospital’s oncology clinic and also represents the Central Swedish region in the national care program group for malignant melanoma and is in the steering group for the SweMR. and SMSG.